AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,484.00p
   
  • Change Today:
      48.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.64m
  • Volume: 1,135,298
  • Market Cap: £162,569m
  • RiskGrade: 123

Latest Deals

Traded Action Notifier PriceAmountValue
21-May-25 Transfer From Pascal Soriot 0.000p 8,970 £0.00
30-Apr-25 Buy Karen Knudsen 5,376.72p 1,400 £75,274.07

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
30-Apr-25 Buy Karen Knudsen 5,376.72p 1,400 £75,274.07
21-May-25 Transfer From Pascal Soriot 0.000p 8,970 £0.00

Director Shareholdings

Notifier Holding Value*
Pascal Soriot 882,891 £92,562,292
Aradhana Sarin 118,367 £12,409,596
Marcus Wallenberg 60,028 £6,293,336
Michel Demare 10,000 £1,048,400
Philip A J Broadley 8,025 £841,341
Tony Mok 3,500 £366,940
Sheri McCoy 1,736 £182,002
Diana Layfield 1,400 £146,776
Karen Knudsen 1,400 £146,776
Euan Ashley 1,150 £120,566
Nazneen Rahman 1,017 £106,622
Anna Manz 487 £51,057

Major Shareholders

Notifier** Holding Value*
BlackRock, Inc 100,885,181 £10,576,802,376
Oddo Meriten Asset Management SA 100,885,181 £10,576,802,376
The Capital Group Companies, Inc. 77,540,115 £8,129,305,657
Wellington Management Company LLP 65,118,411 £6,827,014,209
Investor AB 51,587,810 £5,408,466,000

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,484.00p
Change Today 48.00p
% Change 0.46 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 1,135,298
Shares Issued 1,550.64m
Market Cap £162,569m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.63% below the market average93.63% below the market average93.63% below the market average93.63% below the market average93.63% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
23.26% below the market average23.26% below the market average23.26% below the market average23.26% below the market average23.26% below the market average
23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average
Income
60.71% below the market average60.71% below the market average60.71% below the market average60.71% below the market average60.71% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
86.57% above the market average86.57% above the market average86.57% above the market average86.57% above the market average86.57% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 27-May-2025

Time Volume / Share Price
16:03 0 @ 10,522.00p
16:03 0 @ 10,522.00p
16:03 0 @ 10,522.00p
15:54 0 @ 10,530.00p
15:54 0 @ 10,530.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page